{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:37:28Z","timestamp":1792643848943,"version":"4.5.0"},"reference-count":28,"publisher":"VM Media SP. zo.o VM Group SK","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologia i Neurochirurgia Polska"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pjnns.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T20:56:44Z","timestamp":1469825804000},"page":"418-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Improvement of quality of life after therapeutic plasma exchange in patients with myasthenic crisis"],"prefix":"10.5603","volume":"50","author":[{"given":"Izabela","family":"Rozmilowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Adamczyk-Sowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Pierzchala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Misiolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"issue":"116","key":"10.1016\/j.pjnns.2016.07.005_bib0145","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"issue":"357","key":"10.1016\/j.pjnns.2016.07.005_bib0150","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","author":"Vincent","year":"2001","journal-title":"Lancet"},{"issue":"48\u201349","key":"10.1016\/j.pjnns.2016.07.005_bib0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.pjnns.2016.07.005_bib0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ane.12271","article-title":"Antititin antibody in early- and late-onset myasthenia gravis","volume":"130","author":"Szczudlik","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"10.1016\/j.pjnns.2016.07.005_bib0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1468-1331.2008.02176.x","article-title":"MuSK-positive myasthenia gravis is rare in the Polish population","volume":"15","author":"Kostera-Pruszczyk","year":"2008","journal-title":"Eur J Neurol"},{"issue":"284","key":"10.1016\/j.pjnns.2016.07.005_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2015.04.015","article-title":"MuSK autoantibodies in myasthenia gravis detected by cell based assay \u2013 a multinational study","volume":"15","author":"Tsonis","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.pjnns.2016.07.005_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcn152","article-title":"Myasthenic crisis","volume":"102","author":"Chaudhuri","year":"2009","journal-title":"QJM: Int J Med"},{"issue":"24","key":"10.1016\/j.pjnns.2016.07.005_bib0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2004-829595","article-title":"Myasthenia gravis: management of myasthenic crisis and perioperative care","author":"Juel","year":"2004","journal-title":"Semin Neurol"},{"issue":"13","key":"10.1016\/j.pjnns.2016.07.005_bib0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CND.0b013e31822c34dd","article-title":"Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study","author":"Heatwole","year":"2011","journal-title":"J Clin Neuromuscul Dis"},{"issue":"12","key":"10.1016\/j.pjnns.2016.07.005_bib0190","first-page":"1147","article-title":"Measuring disease: a rewiev of disease \u2013 specific quality of life measurement scales","author":"Bowling","year":"2003","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.pjnns.2016.07.005_bib0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.pjnns.2016.07.005_bib0200","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0272-6386(12)80135-1","article-title":"Therapeutic plasma exchange: complications and management","volume":"23","author":"Mokrzycki","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.pjnns.2016.07.005_bib0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5603\/AIT.2013.0002","article-title":"Complications in patients treated with plasmapheresis in the intensive care unit","volume":"45","author":"Szczeklik","year":"2013","journal-title":"Anaesthesiol Intens Ther"},{"issue":"5","key":"10.1016\/j.pjnns.2016.07.005_bib0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures","volume":"22","author":"Shemin","year":"2007","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.pjnns.2016.07.005_bib0215","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jca.21391","article-title":"Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: registry of the first 500 sessions","volume":"30","author":"C\u00f3rdoba","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.pjnns.2016.07.005_bib0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"October (10)","key":"10.1016\/j.pjnns.2016.07.005_bib0225","first-page":"1166","article-title":"Quality of life questionnaire SF-36 \u2013 Polish version","volume":"67","author":"Tylka","year":"2009","journal-title":"Kardiol Pol"},{"issue":"31","key":"10.1016\/j.pjnns.2016.07.005_bib0230","first-page":"247","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs","author":"Horney","year":"1993","journal-title":"Med Care"},{"issue":"December (12)","key":"10.1016\/j.pjnns.2016.07.005_bib0235","doi-asserted-by":"crossref","first-page":"e114060","DOI":"10.1371\/journal.pone.0114060","article-title":"Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development","volume":"9","author":"Heldal","year":"2014","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.pjnns.2016.07.005_bib0240","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/CND.0b013e3181660807","article-title":"A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis","author":"Jansen","year":"2008","journal-title":"J Clin Neuromuscul Dis"},{"issue":"76","key":"10.1016\/j.pjnns.2016.07.005_bib0245","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","author":"Barth","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pjnns.2016.07.005_bib0250","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1525-1594.2001.06717.x","article-title":"Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis","author":"Ronager","year":"2001","journal-title":"Artif Organs"},{"issue":"84","key":"10.1016\/j.pjnns.2016.07.005_bib0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jnnp-2011-301449","article-title":"Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis","author":"Barnett","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.pjnns.2016.07.005_bib0260","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00415-011-5913-4","article-title":"Psychosocial aspects in myasthenic patients treated by plasmapheresis","volume":"258","author":"Chen","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.pjnns.2016.07.005_bib0265","unstructured":"Boldingh M, Dekker L, Maniaol A, et al. An up-date on health-related quality of life in myasthenia gravis results from population based cohorts. http:\/\/link.springer.com\/article\/10.1186%2Fs12955-015-0298-1."},{"issue":"25","key":"10.1016\/j.pjnns.2016.07.005_bib0270","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/mus.10035","article-title":"Quality of life in patients with myasthenia gravis","author":"Padau","year":"2002","journal-title":"Muscle Nerve"},{"issue":"93","key":"10.1016\/j.pjnns.2016.07.005_bib0275","first-page":"1167","article-title":"Quality of life of myasthenia gravis","author":"Kulkantrakorn","year":"2010","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.pjnns.2016.07.005_bib0280","first-page":"71","article-title":"Polska wersja kwestionariusza SF-36v2 do badania jako\u015bci \u017cycia","author":"\u017bo\u0142nierczyk-Zreda","year":"2009","journal-title":"CIOP PIB"}],"container-title":["Neurologia i Neurochirurgia Polska"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384316300743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384316300743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:41:06Z","timestamp":1546944066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028384316300743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0028384316300743"],"URL":"https:\/\/doi.org\/10.1016\/j.pjnns.2016.07.005","relation":{},"ISSN":["0028-3843"],"issn-type":[{"value":"0028-3843","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of quality of life after therapeutic plasma exchange in patients with myasthenic crisis","name":"articletitle","label":"Article Title"},{"value":"Neurologia i Neurochirurgia Polska","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pjnns.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}